Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects

L A Sechi1, S De Marchi

  • 1Hypertension Unit, Department of Experimental and Clinical Pathology and Medicine, Internal Medicine, University of Udine, Italy. Sechi@uniud.it

Insights

In hypertensive individuals, lipoprotein(a) (Lp(a)) shows a stronger association with clotting factors like fibrinogen and D-dimer compared to normotensive individuals. This suggests an accelerated risk of atherothrombosis in hypertension patients.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Genetics

Background:

  • Coagulation factors are established predictors of cardiovascular damage in the general population.
  • Lipoprotein(a) (Lp(a)) and apolipoprotein(a) (apo(a)) isoforms are implicated in cardiovascular risk.
  • Hypertension is a significant risk factor for cardiovascular disease.

Purpose of the Study:

  • To investigate the relationships between cardiovascular risk factors, Lp(a), and hemostatic variables in hypertensive subjects.
  • To characterize apo(a) isoforms in hypertensive individuals.
  • To compare these relationships in hypertensive versus normotensive subjects.

Main Methods:

  • Measured plasma lipids, apolipoproteins, Lp(a), apo(a) isoforms, fibrinogen, and coagulation activation markers in 389 untreated essential hypertensive patients and 323 normotensive controls.
  • Analyzed correlations between Lp(a), cardiovascular risk factors, and hemostatic variables.
  • Investigated apo(a) phenotypes to understand the genetic basis of observed relationships.

Main Results:

  • In hypertensive subjects, Lp(a) correlated significantly with age, apo-B, fibrinogen, and D-dimer, but not with other traditional risk factors.
  • The association between Lp(a) and fibrinogen/D-dimer was stronger in hypertensive individuals than in normotensive controls.
  • Elevated fibrinogen, D-dimer, and Lp(a) were independently associated with atherosclerotic disease; Lp(a) levels inversely correlated with apo(a) isoform size.

Conclusions:

  • The relationship between Lp(a) and clotting variables is significantly stronger in hypertensive subjects.
  • This enhanced association suggests accelerated atherothrombosis progression in hypertensive patients.
  • Lp(a) and specific clotting factors represent key targets for managing cardiovascular risk in hypertension.
Abstract

Related Concept Videos

Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...